Do drug treatment facilities really lower property values? Finally, an answer

When it comes to rehab centers, many people think ‘not in my backyard.’.....»»

Category: topSource: marketwatchJan 11th, 2019

Is sea rise wrecking coastal home values? The answer: Maybe

Some research suggests rising sea levels and flooding brought by global warming are harming coastal property values, but how much is an open question......»»

Category: topSource: moneycentralMay 19th, 2019

Analysis: Cannabis Shops Linked To Lower Crime, Increased Property Values

By David Downs California Bureau Chief, read more.....»»

Category: blogSource: benzingaMay 14th, 2019

A major pillar of China"s economy has passed the "tipping point" and could slow further, analyst says

China Photos/Getty Images China started a shanty town renovation program in 2015 in an effort to drive home sales in lower-tier cities, helping lift the country's property values over the past few years. To calm the red-hot hous.....»»

Category: topSource: businessinsiderDec 6th, 2018

Homebuilder Sentiment Slips For First Time In 2019

For the first time in 2019, sentiment among US homebuilders dropped in June signaling that lower mortgage rates are failing to give the housing market a sustained boost amid property prices that remain out of reach for many buyers. The headline .....»»

Category: blogSource: zerohedge15 hr. 13 min. ago

Orgenesis shares soar 19% premarket after FDA grants orphan designation to insulin tech

Orgenesis Inc. shares soared 19% in premarket trade Monday, after the U.S. Food and Drug Administration granted Orphan Drug Designation to the company's Autologous Insulin Producing cells as a cell replacement therapy for the treatment of severe hypogl.....»»

Category: topSource: marketwatch18 hr. 13 min. ago

Property values in my neighborhood are skyrocketing and friends tell me to "just buy already," but here"s why I won"t

Jon Bilous / Megan DeMatteo lives in an up-and-coming Baltimore neighborhood where ri.....»»

Category: topSource: businessinsiderJun 15th, 2019

United States suspends WTO intellectual property litigation against China

The United States has halted a World Trade Organization dispute over China's treatment of intellectual property rights until Dec. 31, the WTO dispute panel hearing the case said in a statement published on Friday......»»

Category: topSource: reutersJun 14th, 2019

How Ketamine Opens a New Era for Depression Treatment

Researchers have discovered that ketamine, a drug of choice for club-goers for decades, can be used to fight severe cases of the blues. For more than three decades, patients seeking treatment for depression in the U.S. have been steered primaril.....»»

Category: topSource: washpostJun 14th, 2019

Chicago biotech sues Third Rock, bluebird bio CEO over gene therapy license

A Chicago biotech claims in a new lawsuit that Cambridge venture capital firm Third Rock Ventures and bluebird bio CEO Nick Leschly worked to hinder its drug development efforts so it could more easily obtain a key part of its intellectual property. E.....»»

Category: topSource: bizjournalsJun 13th, 2019

FDA Greenlights Merck"s Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer

Keytruda, Merck & Co., Inc. read more.....»»

Category: blogSource: benzingaJun 11th, 2019

Actinogen Disappoints For Alzheimer"s Treatment, An Analysis Of Research Findings Identifies Major Issues With The Drug"s Rationale

Actinogen Disappoints For Alzheimer"s Treatment, An Analysis Of Research Findings Identifies Major Issues With The Drug"s Rationale.....»»

Category: topSource: seekingalphaJun 7th, 2019

Following property sale, nursing home company plans $4.5M upgrades at two sites

A Syracuse nursing home company is planning $4.5 million in upgrades and expansions at its two Western New York assisted living facilities. Peregrine Senior Living is investing close to $3 million at its facility in Orchard Park; and another $1.5 .....»»

Category: topSource: bizjournalsJun 6th, 2019

Eli Lilly"s Emgality gets FDA approval for episodic cluster headaches

Eli Lilly & Co. said Wednesday Emgality injection was approved by the U.S. Food and Drug Administration for the treatment of episodic cluster headache in adults......»»

Category: topSource: marketwatchJun 5th, 2019

InflaRx stock plummets 84% after failure of skin treatment

Shares of InflaRx fell 84% in premarket trade Wednesday after the biotech said its drug for an inflammatory skin disorder called hidradenitis suppurativa failed to show a statistically significant response in .....»»

Category: topSource: marketwatchJun 5th, 2019

San Francisco May Lock Up Mentally Ill Homeless People

San Francisco authorities are expected to consider a Tuesday proposal that would force mentally ill drug addicts into treatment centers against their will, according to ABC News.  Known as conservatorship, the program has the endorsement of Mayor Lon.....»»

Category: blogSource: zerohedgeJun 4th, 2019

Cannabis Watch: Cannabis stocks turn lower ahead of FDA hearing on weed and its ingredients

Cannabis stocks turned lower Thursday, a day ahead of a key hearing by the U.S. Food and Drug Administration, seeking information and data on the substance and its ingredients with the aim of creating a regulatory framework for CBD......»»

Category: topSource: marketwatchMay 31st, 2019

May is busy month for property tax team

Attorney Peter Allen Weinmann and his team of lawyers look forward to later this week when their big deadline for the year passes and they can finally take a breather. Grievance Day, usually the fourth Tuesday in May, comes and goes for most people. But.....»»

Category: topSource: bizjournalsMay 27th, 2019

Republic Bank takes Union Square corner

RFR announced that Republic First Bancorp signed a 15-year retail lease at 90 Fifth Avenue. The lease agreement totals 7,748 s/f, including 3,920 s/f on the ground floor and 3,828 s/f on the lower level of the 140,000 s/f property, which.....»»

Category: realestateSource: realestateweeklyMay 24th, 2019

Novartis gets FDA nod for advanced breast-cancer treatment

Novartis AG said late Friday the U.S. Food and Drug Administration has approved one of its treatments for a type of advanced breast cancer afflicting patients carrying a gene.....»»

Category: topSource: marketwatchMay 24th, 2019

FDA to rule this week on Incyte"s bid for wider use of Jakafi

The Food and Drug Administration is expected to rule late this week on Incyte Corp.’s effort to get a wide approval for its flagship Jakafi medication. Jakafi is already approved as a treatment for polycythemia vera, a chronic type of bone marrow di.....»»

Category: topSource: bizjournalsMay 22nd, 2019